Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D1EU | ISIN: BE6333353298 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BONYF NV Chart 1 Jahr
5-Tage-Chart
BONYF NV 5-Tage-Chart
Dow Jones News
490 Leser
Artikel bewerten:
(2)

bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions

DJ bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions

bonyf NV / Key word(s): Regulatory Admission/Regulatory Approval 
bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions 
09-Dec-2024 / 15:42 CET/CEST 
=---------------------------------------------------------------------------------------------------------------------- 
bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions 
Knokke-Heist (Belgium), 9 December 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort 
expert, is a Euronext Paris listed company and specializes in the development, production, and marketing of oral, 
denture, orthodontic, and wound care products. As a leader in dental care innovation, bonyf is committed to advancing 
oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant 
milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union's Medical 
Device Regulation (MDR), marking a new chapter in its pursuit of excellence. 
bonyf's R&D team is excited to have obtained the MDR certification for its portfolio of medical devices. This 
achievement reflects the company's ongoing commitment to meeting the highest standards of quality, safety, and 
performance in the dental and denture care sectors. The MDR certification is a rigorous process, ensuring that each 
product complies with the European Union's stringent requirements for medical devices, providing consumers with the 
assurance that bonyf's products are safe and reliable for use in healthcare settings. 
"We are thrilled to have achieved this certification, which demonstrates our ongoing commitment to innovation, quality, 
and patient safety," said Jean-Pierre Bogaert, CEO of bonyf group. "This accomplishment not only opens new market 
opportunities within Europe but also reinforces our position as a trusted leader in the oral care and medical device 
industry." 
As part of its ongoing commitment to research and development, bonyf will continue to enhance its product offerings, 
integrating the latest scientific advancements with user-centric designs to address the evolving needs of oral care 
professionals and their patients. 
For more information, visit bonyf.com or contact investor@bonyf.com. 
bonyf's strengths 
   -- Products with patented formulations 
   -- Produced in Switzerland compliant with stringent international quality regulations 
   -- Proven clinical efficacy 
   -- Commercial presence in 37 countries 
   -- Prospects for solid growth and rapid profitability 
   -- A fast-growing oral and dental care market 
 
About bonyf 
Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care 
products. bonyf is a forward-thinking company committed to revolutionizing oral care through innovation and research. 
With a focus on quality and efficacy, bonyf develops cutting-edge products designed to enhance the well-being of 
individuals worldwide. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real 
difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in 
the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries 
worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong 
future development, driven by the fast-growing oral and dental care market. 
For more information about bonyf and its innovative oral care products, please visit www.bonyf.com. 
 
bonyf 
Jean-Pierre Bogaert 
investor@bonyf.com 

-----------------------------------------------------------------------------------------------------------------------

Dissemination of a Financial Wire News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Language:   English 
Issuer:    bonyf NV 
       Kalvekeetdijk 179, box 105 
       8300 Knokke-Heist 
       Belgium 
Phone:    +41 79 412 42 79 
E-mail:    president@bonyf.com 
Internet:   www.bonyf.com 
ISIN:     BE6333353298 
EQS News ID: 2047289 
 
End of Announcement - EQS News Service 
=------------------------------------------------------------------------------------ 

2047289 09-Dec-2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=0ec9030ef48d41c31a75deb8886f019f

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=c82ef9001a260270c8a194e4e4be8c0c

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=ea5fa072535f7a8eaf743972b9fed6b1

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2047289&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

December 09, 2024 09:42 ET (14:42 GMT)

© 2024 Dow Jones News
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.